Members of the WHO Programme
for International Drug Monitoring
for International Drug Monitoring
UMC publications
Gattepaille L.
Using the WHO database of spontaneous reports to build joint vector representations of drugs and adverse drug reactions, a promising avenue for pharmacovigilance. 2019 IEEE International Conference on Healthcare Informatics (ICHI), Xi'an, China, 2019, pp. 1-6, doi: 10.1109/ICHI.2019.8904551.
Using the WHO database of spontaneous reports to build joint vector representations of drugs and adverse drug reactions, a promising avenue for pharmacovigilance. 2019 IEEE International Conference on Healthcare Informatics (ICHI), Xi'an, China, 2019, pp. 1-6, doi: 10.1109/ICHI.2019.8904551.
van Stekelenborg J, Ellenius J, Maskell S, Bergvall T, Caster O et al
Recommendations for the Use of Social Media in Pharmacovigilance: Lessons from IMI WEB-RADR. Drug Safety, Vol. 42, 1393–1407(2019)
Date: 2019-08-24
Recommendations for the Use of Social Media in Pharmacovigilance: Lessons from IMI WEB-RADR. Drug Safety, Vol. 42, 1393–1407(2019)
Date: 2019-08-24
Rocca E, Copeland S, Edwards IR
Pharmacovigilance as Scientific Discovery: An Argument for Trans-Disciplinarity. Drug Safety, Vol. 42, 1115–1124 (2019)
Date: 2019-10-01
Pharmacovigilance as Scientific Discovery: An Argument for Trans-Disciplinarity. Drug Safety, Vol. 42, 1115–1124 (2019)
Date: 2019-10-01
Watson S, Caster O, Rochon PA, den Ruijter H
Reported adverse drug reactions in women and men: Aggregated evidence from globally collected individual case reports during half a century. EClinicalMedicine. 2019 Oct 25;17:100188
Date: 2019-10-25
Reported adverse drug reactions in women and men: Aggregated evidence from globally collected individual case reports during half a century. EClinicalMedicine. 2019 Oct 25;17:100188
Date: 2019-10-25
Wakao R, Taavola H, Sandberg L, Iwasa E, Soejima S, Chandler RE, Norén GN
Data-Driven Identification of Adverse Event Reporting Patterns for Japan in VigiBase, the WHO Global Database of Individual Case Safety Reports. Drug Safety, Vol. 42, 1487–1498 (2019)
Date: 2019-12-02
Data-Driven Identification of Adverse Event Reporting Patterns for Japan in VigiBase, the WHO Global Database of Individual Case Safety Reports. Drug Safety, Vol. 42, 1487–1498 (2019)
Date: 2019-12-02
Dietrich J, Gattepaille L, Anne Grum B, Jiri L, Lerch M, Sartori D, Wisniewski A
Adverse Events in Twitter - Development of a Benchmark Reference Dataset: Results from IMI WEB-RADR. Drug Safety (2020) 43:467–478.
Date: 2020-01-29
Adverse Events in Twitter - Development of a Benchmark Reference Dataset: Results from IMI WEB-RADR. Drug Safety (2020) 43:467–478.
Date: 2020-01-29
Caster O, Aoki Y, Gattepaille L, Grundmark B
Disproportionality Analysis for Pharmacovigilance Signal Detection in Small Databases or Subsets: Recommendations for Limiting False-Positive Associations. Drug Safety (2020) 43:479–487.
Date: 2020-02-01
Disproportionality Analysis for Pharmacovigilance Signal Detection in Small Databases or Subsets: Recommendations for Limiting False-Positive Associations. Drug Safety (2020) 43:479–487.
Date: 2020-02-01
de Leon J, J. Sanz E, Norén GN, De las Cuevas C
Pneumonia may be more frequent and have more fatal outcomes with clozapine than with other second‐generation antipsychotics. World Psychiatry. 2020 Feb; 19(1): 120–121. Published online 2020 Jan 10. doi: 10.1002/wps.20707
Date: 2020-02-03
Pneumonia may be more frequent and have more fatal outcomes with clozapine than with other second‐generation antipsychotics. World Psychiatry. 2020 Feb; 19(1): 120–121. Published online 2020 Jan 10. doi: 10.1002/wps.20707
Date: 2020-02-03
Lagerlund O, Strese S, Fladvad M, Lindquist M
WHODrug: A Global, Validated and Updated Dictionary for Medicinal Information. Ther Innov Regul Sci. 2020 Feb 20. doi: 10.1007/s43441-020-00130-6
Date: 2020-02-20
WHODrug: A Global, Validated and Updated Dictionary for Medicinal Information. Ther Innov Regul Sci. 2020 Feb 20. doi: 10.1007/s43441-020-00130-6
Date: 2020-02-20
Chandler RE, McCarthy D, Delumeau JC, Harrison-Woolrych M
The Role of Pharmacovigilance and ISoP During the Global COVID-19 Pandemic. Drug Saf. 2020 Jun;43(6):511-512. doi: 10.1007/s40264-020-00941-4
Date: 2020-05-07
The Role of Pharmacovigilance and ISoP During the Global COVID-19 Pandemic. Drug Saf. 2020 Jun;43(6):511-512. doi: 10.1007/s40264-020-00941-4
Date: 2020-05-07
Chandler RE
Optimizing safety surveillance for COVID-19 vaccines. Nat Rev Immunol. 2020 Jun 17:1–2. doi: 10.1038/s41577-020-0372-8.
Date: 2020-06-17
Optimizing safety surveillance for COVID-19 vaccines. Nat Rev Immunol. 2020 Jun 17:1–2. doi: 10.1038/s41577-020-0372-8.
Date: 2020-06-17
Sandberg L, Taavola H, Aoki Y, Chandler R, Norén GN.
Risk Factor Considerations in Statistical Signal Detection: Using Subgroup Disproportionality to Uncover Risk Groups for Adverse Drug Reactions in VigiBase. Drug Saf. 2020 Jun 20. doi: 10.1007/s40264-020-00957-w.
Date: 2020-06-20
Risk Factor Considerations in Statistical Signal Detection: Using Subgroup Disproportionality to Uncover Risk Groups for Adverse Drug Reactions in VigiBase. Drug Saf. 2020 Jun 20. doi: 10.1007/s40264-020-00957-w.
Date: 2020-06-20
Härmark L, Weits G, Meijer R, Santoro F, Norén GN, van Hunsel F.
Communicating Adverse Drug Reaction Insights Through Patient Organizations: Experiences from a Pilot Study in the Netherlands. Drug Saf. 2020 May 16. doi: 10.1007/s40264-020-00932-5.
Date: 2020-06-25
Furlan G, Caduff-Janosa P, Sottosanti L, Cappello E, Valdiserra G, Tuccori M.
Drug Safety in Geriatric Patients: Current Status and Proposed Way Forward. Drug Saf. 2020 Jun 4. doi: 10.1007/s40264-020-00949-w
Date: 2020-06-25
Gattepaille LM, Hedfors Vidlin S, Bergvall T, Pierce CE, Ellenius J
Prospective Evaluation of Adverse Event Recognition Systems in Twitter: Results from the Web-RADR Project
Drug Saf. 2020 May 14. doi: 10.1007/s40264-020-00942-3
Date: 2020-06-25
Chandler RE
Nintedanib and ischemic colitis: Signal assessment with the integrated use of two types of real-world evidence, spontaneous reports of suspected adverse drug reactions, and observational data from large health-care databases. Pharmacoepidemiol Drug Saf. 2020 May 12. doi: 10.1002/pds.5022
Date: 2020-06-25
Communicating Adverse Drug Reaction Insights Through Patient Organizations: Experiences from a Pilot Study in the Netherlands. Drug Saf. 2020 May 16. doi: 10.1007/s40264-020-00932-5.
Date: 2020-06-25
Furlan G, Caduff-Janosa P, Sottosanti L, Cappello E, Valdiserra G, Tuccori M.
Drug Safety in Geriatric Patients: Current Status and Proposed Way Forward. Drug Saf. 2020 Jun 4. doi: 10.1007/s40264-020-00949-w
Date: 2020-06-25
Gattepaille LM, Hedfors Vidlin S, Bergvall T, Pierce CE, Ellenius J
Prospective Evaluation of Adverse Event Recognition Systems in Twitter: Results from the Web-RADR Project
Drug Saf. 2020 May 14. doi: 10.1007/s40264-020-00942-3
Date: 2020-06-25
Chandler RE
Nintedanib and ischemic colitis: Signal assessment with the integrated use of two types of real-world evidence, spontaneous reports of suspected adverse drug reactions, and observational data from large health-care databases. Pharmacoepidemiol Drug Saf. 2020 May 12. doi: 10.1002/pds.5022
Date: 2020-06-25
Hult S, Sartori D, Bergvall T, Hedfors Vidlin S, Grundmark B, Ellenius J, Norén GN
A Feasibility Study of Drug–Drug Interaction Signal Detection in Regular Pharmacovigilance. Drug Safety, Vol. 43, 775–785 (2020).
Date: 2020-07-17
A Feasibility Study of Drug–Drug Interaction Signal Detection in Regular Pharmacovigilance. Drug Safety, Vol. 43, 775–785 (2020).
Date: 2020-07-17
